Europe Fluorescent Immunoassay Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) 

No. of Pages: 168
Report Code: BMIRE00025661
Category: Life Sciences
Europe Fluorescent Immunoassay Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Fluorescent Immunoassay Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Fluorescent Immunoassay Market Regional Analysis

6.2 Europe Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)
6.3 Europe Fluorescent Immunoassay Market Forecast Analysis

7. Europe Fluorescent Immunoassay Market Analysis – by Product Type

7.1 ELISA
  • 7.1.1 Overview
  • 7.1.2 ELISA: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Rapid Lateral Flow Immunoassay
  • 7.2.1 Overview
  • 7.2.2 Rapid Lateral Flow Immunoassay: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Fluorescent Immunoassay Market Analysis – by Application

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Fluorescent Immunoassay Market Analysis – by End User

9.1 Hospitals & Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals & Clinics: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Centers
  • 9.2.1 Overview
  • 9.2.2 Diagnostic Centers: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Pharmaceutical & Biotechnology Companies: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academic & Research Institutes: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Fluorescent Immunoassay Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Europe Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 UK: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.1.2 UK: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.1.3 UK: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.2.2 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.2.3 Germany: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.3 France: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 France: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.3.2 France: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.3.3 France: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.4.2 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.4.3 Russia: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.5.2 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.5.3 Italy: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.6.2 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.6.3 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ortho Clinical Diagnostics Holdings plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Quidel Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sysmex Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Fluorescent Immunoassay Market

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics Holdings plc
  • Quidel Corporation
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)